Discover the Science of Health
Biomarker Bulletin is an occasionally recurring update of news focused on biomarkers aggregated at BiomarkerCommons.org. Biomarkers are physical, functional or biochemical indicators of normal physiological or disease processes. The individualization of disease management — personalized medicine — is dependent on developing biomarkers that promote specific clinical domains, including early detection, risk, diagnosis, prognosis and predicted response to therapy.
Men face unique health challenges, and one of the most dangerous is their reluctance to seek healthcare. Each year in the week leading up to Father’s Day, Men’s Health Week shines a spotlight on many of the issues that affect the male population. This year, Men’s Health Week runs between June 10th–16th. It is observed as part of the larger Men’s Health Month, which is celebrated during the month of June with screenings, health fairs, media appearances, and other health education and outreach activities.
Jack Andraka has invented a test that can detect early stage pancreatic, ovarian and lung cancer. The cancer sensor is cheaper and faster than today’s gold standard test. In May of this year, Jack Andraka’s groundbreaking research won $75,000 for the first place prize at the Intel International Science and Engineering Fair. Jack plans to put that money towards college, because he’s just 15 years old.
Roche is one of 10 biomedicine companies included in Technology Review’s 50 Most Innovative Companies (TR50) for 2012 [1].
People have increasing opportunities to participate in genetic testing that can indicate their range of risk for developing a disease. Receiving these results does not appreciably drive up or diminish test recipients’ demand for potentially costly follow-up health services, according to a study performed by researchers at the National Institutes of Health and colleagues at other institutions.
